Home » Topics » BioWorld Science

BioWorld Science
RSS

Eli Lilly and Company presents new NTRK1 inhibitors

Dec. 17, 2021

Pfizer synthesizes new JAK1 inhibitors

Dec. 17, 2021

Sanofi patents IL-17A/IL-17RA interaction inhibitors

Dec. 17, 2021

TAXIS Pharmaceuticals divulges bacterial efflux pump inhibitors

Dec. 17, 2021

Factor V/Va-targeting MAb GB-5 promotes thrombus formation in vivo for treating bleeding disorders

Dec. 17, 2021

Targeting S100A7/RAGE signaling pathway inhibits breast tumorigenesis

Dec. 17, 2021

ACE2-IgG4-Fc fusion protein neutralizes SARS-CoV-2, including several variants, at pM concentration

Dec. 17, 2021

The GABA aminotransferase inhibitor OV-329 shows anticonvulsant effects in two rat seizure models

Dec. 17, 2021

First preclinical data presented for chimeric fusion protein AT-03 in amyloidosis

Dec. 17, 2021

SAB-185 neutralizes SARS-CoV-2 Omicron variant in in vitro pseudovirus model

Dec. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...